Sector: health
Conviction from: S&P
52-week range: 62.3894.16
Solventum, a healthcare spinoff from 3M, develops and sells medical, dental, wound-care, health-information and water-filtration products for hospitals and clinicians.
6 tracked filer(s) hold this · 3 opened, 1 added, 1 trimmed in 30-JUN-2026
Aggregate 13FScore 56 — mean of 6 scored holder(s) · buyers (new/add) avg 62. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Paul Tudor Jones / Tudor | 63 | New buy | 120,950 | $9,331,293 | 0.0% |
| Louis Bacon / Moore | 53 | New buy | 33,925 | $2,617,314 | 0.0% |
| Steve Cohen / Point72 | 76 | New buy | 102,705 | $7,923,691 | 0.0% |
| Bridgewater | 56 | Added +5167% | 177,921 | $13,726,605 | 0.1% |
| Nelson Peltz / Trian | 50 | Holds (flat) | 8,236,753 | $635,465,494 | 15.0% |
| Ancora | 40 | Trimmed -50% | 731 | $56,397 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
3 disclosed trade(s) by 3 filer(s).
4 disclosed trade(s) by 1 filer(s).
| Trade date | Who | Type | Amount | |
|---|
| 2026-07-01 | Trump, Donald J President | BUY | $15,001 - $50,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,004 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
| 2026-05-14 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |